3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
5
Gastritis
4
Peptic Ulcer
3
Dyspepsia
3
Barrett Esophagus
3
Stomach Ulcer
2
Colorectal Neoplasms
2
Peptic Ulcer Hemorrhage
1
Gastrointestinal Stromal Tumors
1
Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer
1
Dysbiosis
1
Colonic Neoplasms
1
Interventions
nilotinib
2
Sunitinib
2
Imatinib Mesylate
2
regorafenib
1
avapritinib
1
Oxaliplatin
1
Midazolam
1
Lead
1
Esomeprazole
1
Erlotinib Hydrochloride
1
Caffeine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Gastrointestinal Stromal Tumors
×
Esomeprazole
×
Clear all
NCT02800330
2018-08-02
REGORA
Erasmus Medical Center
Phase 4
Completed
31 enrolled